Exhaled Breath Condensate Clinical Trial
Official title:
"Exhaled Breath Condensate" in Allogeneic Stem Cell Recipients and Value in Follow-up
The most effective treatment of hematologic malignancies and some benign hematological diseases is allogeneic stem cell transplantation therapy. Pulmonary complications can occur after allogeneic stem cell transplantation. And these complications effect mortality and morbidity in these patients. In this study we want to investigate the use of exhaled breath condensate (EBC) collection which is a simple and completely noninvasive method. By this way we hope to detect pulmonary complications early. EBC, has been implicated in the pathophysiology of inflammatory airway diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis. EBC, has not been investigated before in patients who underwent stem cell transplantation.
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01241890 -
Prevention of CF Exacerbation in Childhood: PREVEC Study
|
N/A | |
| Completed |
NCT01239238 -
Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER Study
|
N/A | |
| Completed |
NCT01157832 -
Evaluation of the Acute Effect of Water-Pipe Smoking on the Respiratory System
|
N/A | |
| Completed |
NCT04832711 -
A Community Study of the Risk for Obstructive Sleep Apnea and Respiratory Inflammation in an Adult Chinese Population
|
||
| Completed |
NCT06333379 -
Aspergillosis Detection Via EBC-GM in Ventilated Patients
|